Fennec Pharma(FENC) - 2025 Q4 - Earnings Call Transcript

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company Participants Jeff Hackman - CEO Pierre S. Sayad - Chief Medical Officer Robert Andrade - CFO Conference Call Participants Chase Knickerbocker - Senior Research Analyst Madison El-Saadi - Healthcare Equity Research Analyst Raghuram Selvaraju - Managing Director and Equity Research Analyst None - Analyst None - Analyst Operator Good morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter an ...